FDA+ channel feed – Endpoints News

FDA+ channel feed

FDA approves potential blockbuster insomnia drug, a first for Swiss biotech Idorsia

4 years ago

FDA loses FOIA suit over Pfizer vaccine documents, must release 55,000 pages per month

4 years ago

Pfizer and other biopharmas to FDA: Don't include CMOs in new reporting requirements on drug volume

4 years ago

FDA+ roundup: Agency restructures chief scientist's office; First vote on Rob Califf as commissioner pushed to next week

4 years ago

FDA pauses domestic drug inspections again, this time to protect against Omicron

4 years ago

Biotech pulls plans to file accelerated approval after FDA 'change in direction' — shares plummet

4 years ago

FDA adds another drug OK to cap a record win list for 2021

4 years ago

Hitting a new record on drug approvals, the FDA offers a thumbs-up to another atopic dermatitis contender

4 years ago

FDA authorizes new Merck Covid-19 pill despite scientists' concerns on its mechanism of action

4 years ago

It's a year late, but Novartis has finally steered inclisiran to FDA approval. Will it sell?

4 years ago

FDA authorizes the first at-home pills from Pfizer to treat Covid-19

4 years ago

Months after missing its PDUFA date, FDA slaps down Takeda's old Shire drug for eosinophilic esophagitis

4 years ago

FDA slaps a hold on Gilead's injectable HIV treatment over concerns about potential glass contaminants

4 years ago

FDA slams clinical hold on tiny psychedelics player's shot at bringing LSD-assisted therapy to more patients

4 years ago

Alzheimer's experts call on FDA to pull Biogen's Aduhelm

4 years ago

With few treatment options for Omicron, convalescent plasma is ready for a comeback — will the FDA be on board with outpatient use?

4 years ago

FDA clears first long-acting HIV-prevention injectable, giving ViiV claim to historic OK

4 years ago

Aldeyra shares spiral after a late-stage failure in dry eye disease — but that won't stop its pursuit of an NDA

4 years ago

One of Pfizer’s Duchenne gene therapy trials put on hold in wake of patient death as high-dose AAV concerns still cloud field

4 years ago

Bluebird shares tank after FDA puts another hold on its long delayed sickle cell gene therapy

4 years ago

Argenx touts first-in-class win for a rare disease that causes life-threatening muscle weakness

4 years ago

Dealing Biogen another blow, EMA recommends rejecting Aduhelm in three terse paragraphs

4 years ago

FDA permanently lifts in-person requirements for dispensing abortion pills

4 years ago

Uncoordinated and redundant: FDA's Pazdur slams checkpoint inhibitor developers for creating a 'Wild West'

4 years ago

First page Previous page 93 94 959697 98 99 Next page Last page